Aveanna Healthcare selling stockholders offer 15M shares at $13.16 last sale price; company receives no proceeds

Filed August 20, 2026 · ~2 min read

Key Changes

• high

  This is a pure secondary offering: 15,000,000 shares sold by existing stockholders (primarily J.H. Whitney and insiders). The company receives zero proceeds — all sale proceeds go to the selling stockholders, not to Aveanna for operations or growth.

  Use of Proceeds verify on EDGAR →
• high

  Sponsor ownership drops from 50.7% to 44.1% post-offering. Aveanna exits controlled-company status but may use a one-year governance exemption period, delaying full board independence and committee requirements.

  Risk Factors verify on EDGAR →
• medium

  J.H. Whitney is selling 12,496,077 shares (reducing its stake from 12.4% to 5.6%). Current executives selling include CEO Jeff Shaner (90,000 shares), Chairman Rodney Windley (180,000 shares), and CAO Ed Reisz (50,000 shares). Former CEO Tony Strange is selling 180,000 shares.

  Selling Stockholders verify on EDGAR →